---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-028179"
form_type: "8-K"
ticker: "MED"
cik: "0000910329"
company_name: "MEDIFAST INC"
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T11:07:24.163246+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Medifast Q3 revenue down 5.6%; cuts FY2022 revenue and EPS guidance on macro headwinds

## Summary
- Revenue $390.4M (-5.6% YoY); net income $36.2M ($3.27 diluted EPS). Non-GAAP adjusted EPS $3.32.
- Active earning OPTA VIA Coaches 66,200 (+8.5% YoY) but revenue per coach fell 12.9% to $5,897.
- Full-year 2022 revenue guidance cut to $1.51B-$1.59B from $1.58B-$1.66B; non-GAAP EPS to $11.61-$13.05 from $12.70-$14.10.
- Gross margin 72.5% vs 74.3% prior year; cash $69.7M, zero debt; completed $100M ASR program.
- Quarterly dividend of $1.64 per share declared; Euromonitor ranked OPTA VIA #1 U.S. weight loss program by revenue.

## SEC filing metadata
- accession: 0001628280-22-028179
- form_type: 8-K
- ticker: MED
- cik: 0000910329
- company_name: MEDIFAST INC
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/910329/000162828022028179/0001628280-22-028179-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/910329/000162828022028179/med-20221103form8xk.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-028179
- JSON: https://secwatch.observer/filing/0001628280-22-028179.json
- Plain text: https://secwatch.observer/filing/0001628280-22-028179.txt

## Key facts
- Earnings Releases
  MEDIFAST INC reported the third quarter ended September 30, 2022 results: revenue $390.4 million, net income $36.2 million, EPS $3.27 per diluted share.
  - Period: the third quarter ended September 30, 2022
  - Revenue: $390.4 million
  - Net income: $36.2 million
  - EPS: $3.27 per diluted share
  - Result: reported results
  source text: Medifast (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTA VIA® , today reported results for the third quarter ended September 30, 2022. Third Quarter 2022 • Revenue of $390.4 million, with revenue per active earning coach of $5,897 • Independent active earning OPTA VIA Coaches of 66,200 • Net income of $36.2 million (non-GAAP adjusted net income of $36.8 million) • Earnings per diluted share of $3.27 (non-GAAP adjusted EPS of $3.32)
  evidence_url: https://www.sec.gov/Archives/edgar/data/910329/000162828022028179/0001628280-22-028179-index.htm
- Earnings Releases
  MEDIFAST INC reported full-year 2022 results: revenue $1.51 billion to $1.59 billion, EPS $11.61 to $13.05. Guidance lowered.
  - Period: full-year 2022
  - Revenue: $1.51 billion to $1.59 billion
  - EPS: $11.61 to $13.05
  - Guidance: lowered
  - Result: guidance update
  source text: The company now anticipates that full-year 2022 revenue to be in the range of $1.51 billion to $1.59 billion, down from the previously announced range of $1.58 billion to $1.66 billion that was previously disclosed. The company expects full-year 2022 non-GAAP diluted EPS to be in the range of $11.61 to $13.05, down from the previously announced range of $12.70 to $14.10.
  evidence_url: https://www.sec.gov/Archives/edgar/data/910329/000162828022028179/0001628280-22-028179-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.